Humalog (lispro).
Onset within 10- 15 minutes.
Type II
Intermediate acting.
Onset usually young.
Duration 4-6 hours.
Type I
Impaired glucose tolerance or impaired fasting glucose screening after ager 40 with family history of diabetes.
Very long acting (glargine/detemir/Lantus)
No islet cell antibodies.
No peak.
Antibodies to insulin.
Type II
Rapid acting (lispro)
Used for basal dose.
Short acting (regular/Humulin R/Novolin R)
Very long acting (glargine/lantus/levemir)
NPH (Humulin N, Novolin N)
Rapid acting.
Type I
Prediabetes
Decrease in endogenous insulin or increased insulin resistance.
